An open-label trial on the efficacy and tolerability of naltrexone/bupropion SR for treating altered eating behaviours and weight loss in binge eating disorder.
Eat Weight Disord
; 26(3): 779-788, 2021 Apr.
Article
in En
| MEDLINE
| ID: mdl-32356145
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bupropion
/
Binge-Eating Disorder
Type of study:
Observational_studies
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Eat Weight Disord
Journal subject:
GASTROENTEROLOGIA
/
METABOLISMO
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: